IBSA Pharma

Brussel ·KBO/BCE: BE 0795.266.574

Loading dossier…

Metric	This company	Sector median	Position in the sector
Solvency	48.6%	42.8%	better than 59% of 179 sector peers
Net result	€1k	€186k	better than 19% of 179 sector peers
Equity	€35k	€1.19M	better than 11% of 179 sector peers
Gross operating margin	€253k	€184k	better than 57% of 97 sector peers
Staff costs	€233k	€777k	higher than 29% of 136 sector peers

Line item	Code	2025
Balance sheet, Assets
TOTAL ASSETS	20/58	€72k
Current assets	29/58	€72k
Amounts receivable within one year	40/41	€50k
Cash & bank	54/58	€21k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€72k
Equity	10/15	€35k
Contributions / capital	10/11	€25k
Accumulated profits (losses)	14	€10k
Amounts payable	17/49	€37k
Amounts payable within one year	42/48	€37k
Trade debts payable within one year	44	€6k
Income statement
Gross operating margin	9900	€253k
Operating result	9901	€19k
Financial income	75	€0
Financial charges	65	€7k
Result before taxes	9903	€12k
Income taxes	67/77	€11k
Net result for the period	9904	€1k
Result to be appropriated	9905	€1k

NACE primary	Groothandel in farmaceutische en medische artikelen(46460)
Legal form	Private limited company(610)
Incorporation	22-12-2022
Status	Active
Postal code	1000

Summary